Skip to main navigation Skip to search Skip to main content

Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice

Research output: Contribution to journalArticle

Abstract

Not available
Original languageEnglish
Pages (from-to)N/A-N/A
JournalJournal of Antimicrobial Chemotherapy
Issue numbern/a
DOIs
Publication statusPublished - 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Microbiology (medical)
  • Infectious Diseases
  • Pharmacology (medical)

Keywords

  • Health Policy
  • Infectious Diseases
  • Pharmacology (medical)
  • antiretroviral therapy
  • dolutegravir
  • dual therapy
  • lamivudine
  • switch strategy

Fingerprint

Dive into the research topics of 'Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice'. Together they form a unique fingerprint.

Cite this